Announced
Completed
Synopsis
Goldman Sachs and Primavera, an investment firm, led the $108m investment round in Shukun, an AI-powered medical diagnosis firm. Other investors include Sequoia Capital China, Marathon Venture Partners, Jane Street, WT Asset Management and Sage Partners. The fresh funding would be used to invest in R&D of its AI product. Additionally, cash will help increase the pace of commercialization of the company's products.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.